Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1390777 NEW YORK, NY
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$423,433
-$59,556 QoQ
Shares Held
138,831
+29.3% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 162 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. LRMR ranks #251 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in LRMR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $423,433 138,831
2026-03-31 $482,989 107,331
2025-12-31 $441,684 115,928
2025-09-30 $358,658 111,040
2025-06-30 $288,677 99,889
2025-03-31 $215,973 100,453
2024-12-31 $388,751 100,453
2024-09-30 $646,026 98,630
2024-06-30 $977,858 134,877
2024-03-31 $651,031 85,775
2023-12-31 $440,275 96,764
2023-09-30 $386,459 97,838
2023-06-30 $306,232 97,838
2023-03-31 $130,540 28,817
2022-12-31 $119,013 28,817
2022-09-30 $60,713 18,973
2022-06-30 $37,186 18,973
2022-03-31 $76,840 18,973
2021-12-31 $204,718 18,973
2021-09-30 $218,758 18,973
2021-06-30 $186,314 18,973
2021-03-31 $277,194 18,973